Covid vaccine a shot in the arm for Pfizer NZ profit

Pfizer NZ attributed its increased revenue to sales of its covid-19 vaccine. (Image: Deposit Photos)

Wed, 06 Apr 2022

As the government extends free vaccine coverage, pharmaceutical giant Pfizer has reported a ninefold increase in profits in New Zealand.Young people aged 16 and 17 can get booster doses of the Pfizer covid-19 vaccine at least six months after their second dose from Thursday, covid response minister Chris Hipkins said on Wednesday.In its financial results for the year to November 2021, lodged with the Companies Office, the NZ unit of Pfizer reported revenue of $395 million, up from about $50m the previous year.The cost of those sales was $366.2m...

Subscribe to BusinessDesk

Stay informed on business, government and financial developments across New Zealand.

Deeply researched, twice-edited and fact-checked news
Annual subscribers also receive a complimentary subscription to The Wall Street Journal
Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers

You can cancel anytime with two clicks, an email or a phone call.
Find out more.

We are serious about journalism.